TipRanks
Go Ultimate55% OFF

Compare Sonic Healthcare Limited (SAB) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:SABSonic Healthcare LimitedCHF 11.20CHF 5.54B15.85-8.13%NeutralUnlock the CH:SAB analyst price target with TipRanks PremiumCH:SABUnlock the CH:SAB top-analyst price target with TipRanks Premium
AU:HLSHealius LimitedAUD 0.51AUD 359.46M-0.88-42.70%NeutralUnlock the AU:HLS analyst price target with TipRanks PremiumCH:SAB vs AU:HLSUnlock the AU:HLS top-analyst price target with TipRanks Premium
AU:BDXBCAL Diagnostics LimitedAUD 0.08AUD 30.97M-3.48-13.68%―Unlock the AU:BDX analyst price target with TipRanks PremiumCH:SAB vs AU:BDXUnlock the AU:BDX top-analyst price target with TipRanks Premium
AU:GSSGenetic Signatures Ltd.AUD 0.08AUD 17.72M-1.27-74.43%―Unlock the AU:GSS analyst price target with TipRanks PremiumCH:SAB vs AU:GSSUnlock the AU:GSS top-analyst price target with TipRanks Premium
AU:IDXIntegral Diagnostics Ltd.AUD 1.76AUD 659.20M29.59-32.05%Strong BuyUnlock the AU:IDX analyst price target with TipRanks PremiumCH:SAB vs AU:IDXUnlock the AU:IDX top-analyst price target with TipRanks Premium
AU:ACLAustralian Clinical Labs LtdAUD 3.23AUD 615.51M26.0524.23%NeutralUnlock the AU:ACL analyst price target with TipRanks PremiumCH:SAB vs AU:ACLUnlock the AU:ACL top-analyst price target with TipRanks Premium

Performance Comparison

-100%-75%-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:SABSonic Healthcare Limited11.20-0.99-8.13%
AU:HLSHealius Limited0.51-0.38-42.37%
AU:BDXBCAL Diagnostics Limited0.08-0.01-8.89%
AU:GSSGenetic Signatures Ltd.0.08-0.22-73.56%
AU:IDXIntegral Diagnostics Ltd.1.76-0.74-29.54%
AU:ACLAustralian Clinical Labs Ltd3.230.7329.30%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts